Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study

Background/Aims: To investigate the differences in brain glucose consumption between patients with early onset of Alzheimer's disease (EOAD, aged ≤65 years) and patients with late onset of Alzheimer's disease (LOAD, aged >65 years). Methods: Differences in brain glucose consumption between the groups have been evaluated by means of Statistical Parametric Mapping version 8, with the use of age, sex, Mini-Mental State Examination and cerebrospinal fluid values of Aβ1-42, phosphorylated Tau and total Tau as covariates in the comparison between EOAD and LOAD. Results: As compared to LOAD, EOAD patients showed a significant decrease in glucose consumption in a wide portion of the left parietal lobe (BA7, BA31 and BA40). No significant differences were obtained when subtracting the EOAD from the LOAD group. Conclusions: The results of our study show that patients with EOAD show a different metabolic pattern as compared to those with LOAD that mainly involves the left parietal lobe.

• Publication year

  2016

• Venue

  Dementia and Geriatric Cognitive Disorders Extra

• Publication date

  2016-04-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1159/000441776PMID 27195000PMCID 4868930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Slowing the progression of Alzheimer's disease; what works?

  2015cited by this paper
• Functional correlates of t-Tau, p-Tau and A&bgr;1–42 amyloid cerebrospinal fluid levels in Alzheimer’s disease: a 18F-FDG PET/CT study

  2015cited by this paper
• Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment

  2015cited by this paper
• Early Failure of the Default‐Mode Network and the Pathogenesis of Alzheimer's Disease

  2014cited by this paper
• Usefulness of Biomarkers in the Diagnosis and Prognosis of Early-Onset Cognitive Impairment

  2014cited by this paper
• What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.

  2014cited by this paper
• Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment.

  2014cited by this paper
• Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study

  2014cited by this paper
• Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease.

  2013cited by this paper
• Frailty among Alzheimer's disease patients.

  2013cited by this paper
• Meta-analysis of functional network alterations in Alzheimer's disease: toward a network biomarker.

  2013cited by this paper
• Epidemiology of early-onset dementia: a review of the literature

  2013cited by this paper
• A brief history of the resting state: The Washington University perspective

  2012cited by this paper
• Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.

  2012cited by this paper
• Neuropsychological and Neuroimaging Markers in Early Versus Late-Onset Alzheimer’s Disease

  2012cited by this paper
• Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset

  2012cited by this paper
• Early Onset Alzheimer's Disease is Associated with a Distinct Neuropsychological Profile

  2012cited by this paper
• Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD.

  2012cited by this paper
• Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease

  2011cited by this paper
• Early-Versus Late-Onset Alzheimer's Disease: More than Age Alone

  2010cited by this paper
• Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?

  2010cited by this paper
• Could Clinical Profile Influence CSF Biomarkers in Early-onset Alzheimer Disease?

  2010cited by this paper
• New Research Criteria for the Diagnosis of Alzheimer’s Disease Applied in a Memory Clinic Population

  2010cited by this paper
• Functional Alterations in Memory Networks in Early Alzheimer’s Disease

  2010cited by this paper
• CSF biomarker levels in early and late onset Alzheimer's disease.

  2009cited by this paper
• EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2

  2009cited by this paper
• Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study

  2007cited by this paper
• Neuropathology of Alzheimer disease: pathognomonic but not pathogenic

  2006cited by this paper
• The Role of Anterior Cingulate Cortex in Working Memory is Shaped by Functional Connectivity

  2005cited by this paper
• Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease

  2005cited by this paper
• Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia.

  2004cited by this paper
• Standardizzazione di due test di memoria per uso clinico: Breve Racconto e Figura di Rey

  2002cited by this paper
• Presenile dementia syndromes: an update on taxonomy and diagnosis

  2002cited by this paper
• Rey-Osterrieth complex figure: normative values in an Italian population sample

  2002cited by this paper
• Relationship between apoE genotype and CSF β-amyloid (1–42) and tau in patients with probable and definite Alzheimer’s disease

  2000cited by this paper
• Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease.

  2000cited by this paper
• Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia

  1999cited by this paper
• The Mini-Mental State Examination in Alzheimer's Disease and Multi-Infarct Dementia

  1996cited by this paper
• The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery.

  1996cited by this paper
• Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration.

  1996cited by this paper
• Neocortical cell counts in normal human adult aging

  1987cited by this paper
• Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type.

  1984cited by this paper
• Progressive dendritic changes in aging human cortex.

  1975cited by this paper

• Gamma sensory stimulation in mild Alzheimer's dementia: An open‐label extension study

  2025cites this paper
• Differences in baseline cognitive performance between participants with early‐onset and late‐onset Alzheimer's disease: Comparison of LEADS and ADNI

  2024cites this paper
• Addressing the Discrepancies Between Animal Models and Human Alzheimer’s Disease Pathology: Implications for Translational Research

  2024cites this paper
• Systematic review and meta-analysis of repetitive transcranial magnetic stimulation (rTMS) for activities of daily living in Alzheimer's disease

  2024cites this paper
• Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease

  2024cites this paper
• Caregivers’ Burden on Patients with Dementia Having Multiple Chronic Diseases

  2024cites this paper
• Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS

  2024cites this paper
• Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection

  2023cites this paper
• rTMS regulates homotopic functional connectivity in the SCD and MCI patients

  2023cites this paper
• CSF biomarkers for early-onset Alzheimer's disease in Chinese population from PUMCH dementia cohort

  2023cites this paper
• Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease

  2022cites this paper
• Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease

  2022cites this paper
• Early-onset Alzheimer's disease

  2022cites this paper
• Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease

  2021cites this paper
• Quantitative MRI Differences Between Early versus Late Onset Alzheimer’s Disease

  2021cites this paper
• Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European‐DLB consortium project

  2021cites this paper
• Could Early Identification of Changes in Olfactory Function Be an Indicator of Preclinical Neurodegenerative Disease? A Systematic Review

  2020cites this paper
• The Brain Metabolic Correlates of the Main Indices of Neuropsychological Assessment in Alzheimer’s Disease †

  2020cites this paper
• The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer’s disease

  2020cites this paper
• Metabolic connectivity in Alzheimer’s diseases

  2020cites this paper
• Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer’s Disease and Related Disorders

  2020cites this paper
• Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia

  2020cites this paper
• Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Found by Hierarchical Clustering

  2020cites this paper
• Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients?

  2019cites this paper
• Alzheimer’s disease with an early debut

  2019cites this paper
• Early-onset Alzheimer Disease and Its Variants

  2019cites this paper
• Болезнь Альцгеймера с ранним дебютом

  2019cites this paper
• A New Perspective on Alzheimer’s Disease as a Brain Expression of a Complex Metabolic Disorder

  2019cites this paper
• [Molecular imaging of Alzheimer's disease].

  2019influential citation
• [18F] FBB cortical uptake is not related to the age of onset of Alzheimer’s disease

  2019cites this paper
• Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset

  2019cites this paper
• Early-Onset Alzheimer’s Disease and Metabolic Dysfunction, a Comparative Review

  2018influential citation
• Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.

  2018cites this paper
• Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain

  2018cites this paper
• Disease Progression in Early Onset Alzheimer ’ s Dementia Over a Period of 1 Year using 18 F-FDG-PET – A Case Based Approach

  2018cites this paper
• Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42

  2017cites this paper
• Early-Onset Alzheimer Disease.

  2017cites this paper
• PET Imaging for Early Detection of Alzheimer's Disease: From Pathologic to Physiologic Biomarkers.

  2017cites this paper
• 18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer's disease.

  2017cites this paper
• NeuroImage: Clinical

  year unknowncites this paper